At the second annual HLTH Europe event in Amsterdam, Deep Dive editor Eloise McLennan sat down with ABIG Health founder and ...

Technology has also improved immunisation operations with the use of online appointment scheduling that automates ...

It is the second licensing deal that AbbVie has negotiated this year for a trispecific for multiple myeloma, coming in the ...

From robot-assisted surgery to personalised disease treatment - technology can do some truly remarkable things. But while the ...

Biogen says it is the first drugmaker in the US to get FDA approval for a biosimilar of Roche’s $3 billion blockbuster product Actemra. The intravenous biosimilar of IL-6 inhibitor Actemra ...